Patients with severe intestinal epithelialization can be treated with anti-Helicobacter pylori therapy, inhibiting bile reflux to improve gastric motility, increasing mucosal nutrition, and surgery.
Severe intestinal epithelialization is mostly caused by atrophy of the gastrointestinal mucosa. This kind of intestinal epithelialization is mostly caused by the replacement of gastric mucosa by the mucosa of the large intestine or the mucosa of the small intestine.
1. Anti-Helicobacter pylori treatment: if accompanied by Helicobacter pylori infection, it can be treated with quadruple therapy drugs such as omeprazole, clarithromycin, amoxicillin and colloidal bismuth pectin.
2. Inhibit bile reflux to improve gastric motility: aluminum thioglycollate, domperidone, metoclopramide and other drugs can be taken to promote gastric and duodenal motility to avoid bile reflux to improve gastric motility.
3. Increase mucosal nutrition: prostaglandin E, gastric ketone and other drugs can be taken to increase the resistance of the gastric mucosa.
4. Surgical treatment: for patients with heterogeneous hyperplasia, endoscopic mucosal resection or stripping surgery can be considered, and timely postoperative pathological examination to clarify the diagnosis before determining the next step of the surgical program, to prevent the occurrence of cancer.
In addition, patients should pay attention to light diet, avoid spicy, cold, greasy and other stimulating food, quit smoking and alcohol.
The above drugs are prohibited for those who are allergic to them, and they should all be taken in accordance with medical advice. If the patient is diagnosed with severe intestinal epithelial hyperplasia, it is recommended to go to the regular hospital in time, after clarifying the cause of the disease, under the guidance of the doctor for targeted treatment.